CancerConnect News: Patients with recurrent urothelial cancer lived longer when they received Keytruda (pembrolizumab) compared to chemotherapy as second-line treatment, […]
The post Keytruda Improves Survival of Advanced Bladder Cancer appeared first on .
Original Article: Keytruda Improves Survival of Advanced Bladder Cancer